Keywords: متفورمین; Prostate cancer; Metformin; Antineoplastic; Diabetes mellitus;
مقالات ISI متفورمین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: متفورمین; Metformin; Sweet salt; Orally disintegrating tablet; Formulation development; Direct compression;
Keywords: متفورمین; Type 2 diabetes; Hyperglycemia; Hemoglobin A1C; Metformin; Microvascular complications; Macrovascular complications; Individualized care;
Keywords: متفورمین; ARE; Anti-Oxidant Response Element; BBB; Blood-Brain Barrier; CS; Cigarette Smoke; CSE; Cigarette Smoke Extract; 2DM; Type 2 Diabetes Mellitus; FJC; Fluoro-Jade C; FTC; Federal Trade Control; ISO; International Organization for Standardization; MF; Metfor
Keywords: متفورمین; body weight; insulin resistance; metformin; polycystic ovary syndrome; Taiwanese women;
Keywords: متفورمین; Futile cycle; Splanchnic bed; Metformin; Mitochondria;
Keywords: متفورمین; High-fat diet; Metformin; Streptozotocin; Type 2 diabetes mellitus; Vildagliptin;
Keywords: متفورمین; Cellulose nanofiber; Metformin; Melanoma; Metastasis;
Keywords: متفورمین; Metabolic syndrome; Fructose; Bone architecture; Osteoblasts; Metformin;
Keywords: متفورمین; Metformin; Prediabetes; Obesity; Insulin resistance; Children; Adolescents;
Keywords: متفورمین; Metformin; Diabetes; Radiation therapy; Cancer;
Keywords: متفورمین; Antihyperglycemic agents; Comorbidity; Death; Diabetes mellitus; Glucose; Hyperglycemia; Lifestyle; Metformin;
Keywords: متفورمین; Metformin; Prodrugs; Coagulation; Fibrinolysis; Haemostasis; Biguanides;
Keywords: متفورمین; Metformin; Hyperandrogenism; Insulin resistance; Molecular mechanism; PCOS; Rat uterus;
Keywords: متفورمین; Cancer; Aspirin; Metformin; Thalidominde; Drug repurposing; tumor associated inflammation;
Keywords: متفورمین; biliary excretion; drug interactions; efflux pumps; MRP; permeability; ATV; atorvastatin; MET; metformin; 2-OH ATV; 2-hydroxyatorvastatin; CYP; cytochrome P450; MDCK; Madin-Darby canine kidney; MDR; multidrug resistance gene; BCRP; breast cancer resistanc
Keywords: متفورمین; Metformin; 4-Hydroxy-2,6-pyridinedicarboxylic acid; Proton transfer; X-ray structure; Solution study;
Keywords: متفورمین; clinical inertia; factors; metformin; predictors; treatment intensification; type 2 diabetes; United States;
Keywords: متفورمین; Colon cancer; Lung cancer; Metformin; Type 2 diabetes mellitus;
Keywords: متفورمین; GnRH analogues; Aromatase inhibitors; Human recombinant insulin-like growth factor-1; Metformin; Low-dose androgens;
Keywords: متفورمین; Synergy; Ferulic acid; Metformin; Anti-diabetic agents; AMPK, PI-3K; Akt; protein kinase B; AMPK; AMP-activated protein kinase; DM; Diabetes mellitus; G6Pase; glucose-6-phosphatase; IRS; Insulin receptor substrate; LD50; lethal dose 50%; PDK-1; 3-phosphoi
Keywords: متفورمین; prostatic neoplasms; castration-resistant; diabetes mellitus; metformin; docetaxel; mortality; ACG; Johns Hopkins Adjusted Clinical Groups; COX-2; cyclooxygenase-2; CRPC; castration resistant PCa; ICES; Institute for Clinical and Evaluative Sciences; mCRP
Keywords: متفورمین; Intestine; Glucose uptake; Metformin;
Keywords: متفورمین; Ovarian cancer; Cancer stem cells; Anti-angiogenic therapy; Metformin; Salinomycin; XZXHXSATPCNXJR-ZIADKAODSA-N; XZWYZXLIPXDOLR-UHFFFAOYSA-N; CUIHSIWYWATEQL-UHFFFAOYSA-N; FDLYAMZZIXQODN-UHFFFAOYSA-N; KQXDHUJYNAXLNZ-JTGCGTLJSA-N; PBJFMDBOMMKAAG-UHFFFAOYSA-
Keywords: متفورمین; Metformin; 2-Deoxyglucose; ROS; Autophagy; Feline mammary carcinoma cells;
Glycation inhibitors extend yeast chronological lifespan by reducing advanced glycation end products and by back regulation of proteins involved in mitochondrial respiration
Keywords: متفورمین; AGEs; advanced glycation end products; CR; calorie restriction; NR; non-calorie restriction; CLS; chronological lifespan; AMG; aminoguanidine; MET; metformin; HYD; hydralazine; RLS; replicative lifespan; Sch9, threonine/threonine; protein kinase; TOR; Tar
Keywords: متفورمین; Metformin; Insulin; Diabetes mellitus; Antibiotics; NAFLD;
Comparative study between different simple methods manipulating ratio spectra for the analysis of alogliptin and metformin co-formulated with highly different concentrations
Keywords: متفورمین; Alogliptin; Metformin; Spectrophotometry; Validation; Ratio spectra manipulation;
Keywords: متفورمین; Endometrial cancer; Metformin; Type 2 diabetes mellitus; Overall mortality;
Keywords: متفورمین; heart transplantation; diabetes mellitus; metformin; malignancy; reduction;
Keywords: متفورمین; Metformin; Type 2 diabetes; Comorbidity; Mortality; Frailty;
Keywords: متفورمین; Type 2 diabetes; Linagliptin; Metformin; Combination therapy; Asian population;
Keywords: متفورمین; Metformin; ageing; Insulin sensitizer; Lifespan; Longevity; Geroprotection;
Keywords: متفورمین; Gestational diabetes; Metformin; Insulin; Glycaemic control; Perinatal outcomes;
Keywords: متفورمین; Breast cancer; Diabetes; Metformin; Metastasis; Germany;
Keywords: متفورمین; Tuberculosis; Diabetes; Metformin; Host-directed therapy; Immunometabolism; Inflammation;
Keywords: متفورمین; Clomifene citrate; Clomifene citrate resistance; Letrozole; Metformin; Pioglitazone; Polycystic ovary syndrome;
Keywords: متفورمین; Rabeprazole; Metformin; Transporter; Pharmacokinetics; Pharmacodynamics;
Keywords: متفورمین; Prostate cancer; Atorvastatin; Metformin; Clinical trial; Biomarkers; Metabolomics
Keywords: متفورمین; Empagliflozin; Metformin; Simultaneous equation; Chemometry; Partial least squares; Pharmaceutical preparation
Keywords: متفورمین; Metformin; Otitis media; LPS; Human middle ear epitheilial cells;
Keywords: متفورمین; ACTH, Adrenocorticotropic hormone; HOMA1-IR, The homeostatic model assessment 1 of insulin resistance ratio; IGF-1, Insulin-like growth factor-1; SD, Standard deviationDiabetes mellitus; Drugs; Hyperprolactinemia; Metformin
Keywords: متفورمین; Metformin; Endometrial cancer; Prognosis; Diabetes; Obesity;
Keywords: متفورمین; SCI-diabetes; Scottish care information-diabetes; NHS; national health service; NRS; national records Scotland; SES; socioeconomic status; SIMD; Scottish index of multiple deprivation; BMI; body mass index; Pleural mesothelioma; Metformin; Diabetes; Survi
Keywords: متفورمین; Endometrial cancer; Metformin; Window of opportunity; mTOR; Inhibition;
Keywords: متفورمین; 5diabetes; fracture healing; metformin
Keywords: متفورمین; Basal glycaemia; Continuous glucose monitoring; Metformin; Prandial glycaemia; Type 2 diabetes; ADA; American Diabetes Association; AACE; American Association of Clinical Endocrinologist; AUC; area under the curve; BEG; basal excess glycaemia; CGM; contin
Keywords: متفورمین; Metastatic Renal Cell Carcinoma; Metformin; Outcome; Sunitinib;
Keywords: متفورمین; Sensor; Electrodeposition; Metformin; Entacapone; Silver nanoparticles;
Keywords: متفورمین; Wound healing; Insulin; Metformin; Sulfonylurea; Thiazolidinedione; DPP-4 inhibitor;